名称:
                                Pharmacokinetic optimisation of novel indole-2-carboxamide cannabinoid CB1 antagonists
                             
                            
                                摘要:
                                The pharmacokinetic based optimisation of a novel series of indole-2-carboxamide antagonists of the cannabinoid CB1 receptor is disclosed. Compound 24 was found to be a highly potent and selective cannabinoid CB1 antagonist with high predicted human oral bioavailability. (C) 2011 Elsevier Ltd. All rights reserved.
                             
                                                            
                                    DOI:
                                    10.1016/j.bmcl.2011.02.019